References
- Mäkäräinen L, van Beek A, Tuomivaara L, et al. Ovarian function during the use of a single contraceptive implant: implanon compared with Norplant. Fertil Steril 1998;69:714–21
- Varma R, Mascarenhas L. Endometrial effects of etonogestrel (Implanon) contraceptive implant. Curr Opin Obstet Gynecol 2001;13:335–41
- Faculty of Sexual and Reproductive Healthcare. UK Medical eligibility criteria for contraceptive use. UK, 2009;47–67
- Graesslin O, Korver T. The contraceptive efficacy of Implanon®: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008;13:4–12
- Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007;18:CD001326. doi:10/1002/14651858. CD001326.pub2
- Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon® on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 2008;13:13–28
- Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646–53
- Blumenthal PD, Gemzell-Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of Implanon®. Eur J Contracept Reprod Health Care 2008;13:29–36
- Di Carlo C, Sansone A, De Rosa N, et al. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study. 2013 Gynecol Endocrinol 2014;30:53–6
- Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: a review. Contraception 1988;38:129–56
- Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Program of Research, Development and Research Training in Human Reproduction. Contraception 1986;34:253–60
- Fraser IS. Bleeding arising from the use of exogenous steroids. Baillieres Best Pract Res Clin Obstet Gynaecol 1999;13:203–22
- Croxatto HB, Urbancsek J, Massai R, et al. A multicentre efficacy and safety study of the single contraceptive implant Implanon®. Implanon Study Group. Hum Reprod 1999;14:976–81
- Casey PM, Long ME, Marnach ML, Bury JE. Bleeding related to etonogestrel subdermal implant in a US population. Contraception 2011;83:426–30
- Laban M, Abd Alhamid M, Ibrahim EA, et al. Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt. Eur J Contracept Reprod Health Care 2012;17:451–7
- Huber J, Wenzl R. Pharmacokinetics of implanon. An integrated analysis. Contraception 1998;58:85S–90
- Hickey M, Higham JM, Fraser IS. Causes and management of endometrial breakthrough bleeding. Reprod Med Rev 2001;9:153–71
- Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002;8:60–7
- Hickey M, d'Arcangues C. Mechanisms underlying menstrual bleeding disturbances with progestogens. Ernst Schering Res Found Workshop 2005;52:191–217
- Casey PM, Long ME, Marnach ML, et al. Association of body mass index with removal of etonogestrel subdermal implant. Contraception 2013;87:370–4